Imagine a life where managing type 1 diabetes doesn’t dominate every waking moment. For 2,500 more people in Scotland, this is about to become a reality—and it’s all thanks to groundbreaking technology. But here’s where it gets controversial: while this advancement is hailed as ‘life-changing,’ not everyone agrees on how accessible or equitable its rollout truly is. Let’s dive in.
The Scottish Government has announced an additional £6.9 million in funding this year to expand access to closed loop systems, a technology that could revolutionize diabetes care. These systems use a blood glucose sensor connected to an insulin pump to automatically calculate and deliver the right amount of insulin, drastically reducing the need for manual dosage calculations and injections. It’s a game-changer, especially for those who find daily management overwhelming.
During the program’s first year (2024-25), the government invested £8.8 million, providing closed loop systems to around 2,100 people, including approximately 77% of under-18s with type 1 diabetes. In 2025-2026, health boards will receive £7.5 million in ongoing funding, plus the additional £6.9 million to support 2,500 more individuals. And this is the part most people miss: the focus is on prioritizing those who health boards believe will benefit the most, raising questions about who gets left behind.
Remote training, education, and support are provided by healthcare professionals, including specialist nurses and dietitians, ensuring users can confidently manage their new devices. Public Health Minister Jenni Minto emphasized the transformative potential of this technology, stating, ‘Expanding access to closed loop systems will have a life-changing impact on those living with type 1 diabetes.’ She highlighted how these advancements reduce the risk of long-term complications and ease the daily burden of managing the condition.
Minto also reflected on the progress since insulin’s discovery over a century ago, noting how technology continues to improve lives. She expressed hope that beneficiaries of these innovations would lead healthier, more active lives, supported by such treatment advances. ‘We are harnessing innovation, in line with our 10-year Service Renewal Framework, to empower people to better manage their own treatment,’ she added. ‘This will shape a more efficient health and social care system, delivering high-quality care at the right time and place.’
Type 1 diabetes is a lifelong condition affecting over 35,000 people in Scotland, including around 3,340 children. While this funding is a significant step forward, it also sparks debate. Is it enough? Are we doing enough to ensure everyone who needs this technology gets it? These questions linger, inviting us to think critically about equity in healthcare.
What do you think? Is this expansion a fair and sufficient step, or is there more work to be done? Share your thoughts in the comments—let’s keep the conversation going.